Double maintains 1 strategies that include REPL - Replimune Group, Inc.
SeekingAlpha
Delcath's HEPZATO sees rapid sales growth but faces a small market, competition, and moderate efficacy gains.
Yahoo
WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired non-executive employees. The Company granted equity awards to 10 employees as a material inducement to commencing their employment with the Company under the Company’s 2025 Inducement Grant Incentive Compensation Plan (the “Inducement Plan”).
Finnhub
Abstract: 9534 Biosafety analysis from the skin cancer cohorts in the IGNYTE clinical trial of RP1 Trisha M. Wise-Draper1, Caroline Robert2, Michael K. Wong3, Joseph...
Finnhub
Abstract: 9537 Response analysis for injected and non-injected lesions and of the safety and efficacy of superficial and deep/visceral RP1 injection in the registrational cohort of...
Yahoo
- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were generally well tolerated - WOBURN, Mass., June 01, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented two posters hig
Yahoo
WOBURN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management team will present in a fireside chat at the 2025 Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 4:20 PM ET. A simultaneous webcast will be available in the Investors section of Replimune’s website at replimune.com. A replay will be av
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SNDX | 50.70% | $881.99M | -49.03% | 0.00% |
IDYA | 48.91% | $1.94B | -41.80% | 0.00% |
XNCR | 46.98% | $654.06M | -55.34% | 0.00% |
ZYME | 45.39% | $890.11M | +40.15% | 0.00% |
RNA | 44.38% | $3.78B | -20.86% | 0.00% |
DNLI | 44.05% | $2.11B | -29.81% | 0.00% |
KURA | 43.96% | $557.54M | -69.07% | 0.00% |
KYMR | 43.83% | $3.06B | +41.06% | 0.00% |
BEAM | 43.51% | $1.72B | -31.40% | 0.00% |
SRPT | 43.50% | $3.56B | -70.55% | 0.00% |
XENE | 43.22% | $2.51B | -12.05% | 0.00% |
ATXS | 42.63% | $322.80M | -37.49% | 0.00% |
DNTH | 42.05% | $588.85M | -29.58% | 0.00% |
COGT | 41.94% | $806.10M | -15.96% | 0.00% |
RARE | 41.87% | $3.54B | -3.99% | 0.00% |
NRIX | 41.37% | $909.49M | -21.41% | 0.00% |
DAWN | 41.13% | $676.08M | -47.11% | 0.00% |
RCKT | 40.78% | $315.67M | -86.60% | 0.00% |
TCMD | 40.21% | $228.76M | -16.47% | 0.00% |
RVMD | 39.66% | $7.56B | +5.10% | 0.00% |
Current Value
$9.891 Year Return
Current Value
$9.891 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
JOYY | -0.03% | $1.74B | +74.14% | 1.90% |
NAT | 0.04% | $601.37M | -26.99% | 14.64% |
JKS | -0.06% | $976.41M | -17.49% | 0.00% |
CWEN | 0.07% | $3.73B | +18.83% | 5.39% |
STNG | 0.11% | $2.21B | -42.42% | 4.65% |
PARA | 0.11% | $8.02B | +16.91% | 1.68% |
PSQH | -0.13% | $96.54M | -36.34% | 0.00% |
DQ | -0.13% | $928.52M | -26.48% | 0.00% |
MCD | -0.15% | $215.88B | +19.06% | 2.30% |
VIV | 0.19% | $17.40B | +33.60% | 0.51% |
WCN | -0.23% | $49.27B | +13.08% | 0.64% |
KNOP | 0.27% | $226.36M | -2.37% | 1.57% |
CRCT | 0.28% | $1.33B | +1.15% | 3.13% |
AVNW | 0.30% | $279.49M | -25.08% | 0.00% |
AMT | -0.31% | $100.56B | +9.02% | 3.86% |
CBOE | 0.32% | $23.65B | +34.73% | 1.12% |
GIFI | -0.35% | $110.32M | +9.50% | 0.00% |
CODI | 0.37% | $451.42M | -72.86% | 16.30% |
MOMO | 0.39% | $996.43M | +50.51% | 0.00% |
AEP | 0.48% | $54.97B | +16.93% | 3.56% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIFU | -11.88% | $3.21B | -4.38% | 0.00% |
EDU | -9.29% | $7.61B | -37.52% | 0.00% |
MCK | -9.26% | $91.11B | +23.43% | 0.39% |
AQB | -9.20% | $3.14M | -53.66% | 0.00% |
BCH | -8.47% | $15.36B | +32.90% | 6.82% |
FARO | -8.46% | $816.92M | +152.62% | 0.00% |
CCEC | -7.28% | $1.02B | +3.91% | 2.86% |
CELH | -6.73% | $10.61B | -31.35% | 0.00% |
ZCMD | -6.26% | $29.04M | -3.36% | 0.00% |
ULS | -6.21% | $14.17B | +70.68% | 0.72% |
FUBO | -6.00% | $1.08B | +168.64% | 0.00% |
ED | -5.88% | $37.46B | +14.41% | 3.24% |
CREG | -5.64% | $14.41M | -35.06% | 0.00% |
EVGO | -5.39% | $575.58M | +110.29% | 0.00% |
HCA | -5.24% | $89.30B | +9.99% | 0.73% |
FSLR | -4.87% | $18.79B | -35.97% | 0.00% |
LITB | -4.73% | $23.54M | -75.48% | 0.00% |
FMTO | -4.62% | $4.90K | -99.92% | 0.00% |
KO | -4.39% | $305.69B | +13.54% | 3.48% |
VHC | -4.35% | $36.37M | +130.03% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 55.52% | $4.76B | 0.35% |
GNOM | 52.85% | $44.57M | 0.5% |
IBB | 49.79% | $5.43B | 0.45% |
FBT | 44.50% | $1.03B | 0.54% |
PBE | 44.16% | $226.09M | 0.58% |
PTH | 43.81% | $103.32M | 0.6% |
XPH | 42.96% | $153.44M | 0.35% |
ARKG | 42.05% | $974.51M | 0.75% |
BBH | 41.85% | $341.71M | 0.35% |
IWC | 38.78% | $810.66M | 0.6% |
PINK | 38.41% | $132.70M | 0.5% |
IHE | 36.30% | $577.23M | 0.39% |
CPRJ | 34.96% | $47.64M | 0.69% |
VHT | 34.69% | $15.62B | 0.09% |
IWO | 34.43% | $11.29B | 0.24% |
FHLC | 34.36% | $2.48B | 0.084% |
KJUL | 33.67% | $119.49M | 0.79% |
IWM | 33.51% | $64.27B | 0.19% |
VTWO | 33.41% | $12.36B | 0.07% |
IYH | 32.49% | $2.79B | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -23.30% | $104.89M | 0.59% |
VIXY | -22.53% | $181.73M | 0.85% |
BTAL | -20.85% | $291.96M | 1.43% |
TPMN | -16.47% | $30.75M | 0.65% |
IVOL | -14.37% | $358.40M | 1.02% |
FXY | -10.89% | $862.15M | 0.4% |
FTSD | -10.67% | $228.58M | 0.25% |
IBTH | -10.61% | $1.58B | 0.07% |
IBTG | -10.53% | $1.95B | 0.07% |
LDUR | -10.45% | $917.46M | 0.5% |
SHYM | -10.33% | $324.56M | 0.35% |
GBIL | -10.19% | $6.18B | 0.12% |
IEI | -9.74% | $15.30B | 0.15% |
SPTS | -9.21% | $5.78B | 0.03% |
SCHR | -9.11% | $10.71B | 0.03% |
VGSH | -8.97% | $22.51B | 0.03% |
SPTI | -8.95% | $8.66B | 0.03% |
AGZ | -8.85% | $610.44M | 0.2% |
SHY | -8.74% | $23.91B | 0.15% |
IBTK | -8.66% | $434.62M | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TLTW | 0.02% | $1.11B | 0.35% |
BSCW | -0.05% | $881.15M | 0.1% |
ICSH | -0.06% | $6.15B | 0.08% |
IBDZ | 0.06% | $346.24M | 0.1% |
AGGY | 0.08% | $775.70M | 0.12% |
XHLF | -0.10% | $1.66B | 0.03% |
CMBS | 0.11% | $440.96M | 0.25% |
BSCU | -0.15% | $1.60B | 0.1% |
BSCR | 0.16% | $3.60B | 0.1% |
FXC | -0.16% | $89.76M | 0.4% |
BSCV | 0.18% | $1.03B | 0.1% |
IBDT | 0.20% | $2.86B | 0.1% |
FMF | -0.22% | $158.15M | 0.95% |
IGSB | 0.25% | $21.18B | 0.04% |
FXB | 0.28% | $84.96M | 0.4% |
BNO | 0.31% | $90.75M | 1% |
JPST | 0.33% | $31.53B | 0.18% |
IBDV | 0.41% | $1.86B | 0.1% |
LMBS | 0.42% | $5.06B | 0.64% |
AGZD | 0.45% | $110.83M | 0.23% |